Effectiveness and Acceptability of Stellate Ganglion Block for Posttraumatic Stress Disorder Symptoms - Effectiveness
Status:
Completed
Trial end date:
2018-06-09
Target enrollment:
Participant gender:
Summary
This is a multisite, randomized, blinded, sham-procedure-controlled study to evaluate the
efficacy of right-sided stellate ganglion block (SGB) on the acute symptomatology of Post
traumatic Stress Disorder (PTSD), evaluated by the Clinician-Administered PTSD Scale (CAPS-5)
clinical interview at pre-treatment and at 8 weeks. This entry describes the effectiveness
study.The acceptability study is described in a separate entry.
Phase:
N/A
Details
Lead Sponsor:
RTI International
Collaborators:
Landstuhl Regional Medical Center Tripler Army Medical Center Womack Army Medical Center